Daiwa Securities Group Inc. Has $7.13 Million Holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Daiwa Securities Group Inc. boosted its holdings in GE HealthCare Technologies Inc. (NASDAQ:GEHC) by 10.7% in the 4th quarter, according to its most recent filing with the Securities & Exchange Commission. The institutional investor owned 91,195 shares of the company’s stock after purchasing an additional 8,834 shares during the quarter. Daiwa Securities Group Inc.’s holdings in GE HealthCare Technologies were worth $7,130,000 at the end of the most recent reporting period.

A number of other institutional investors have also recently bought and sold shares of GEHC. Ashton Thomas Securities LLC acquired a new stake in shares of GE HealthCare Technologies in the third quarter valued at approximately $26,000. Capital Performance Advisors LLP bought a new position in GE HealthCare Technologies during the 3rd quarter worth $26,000. Darwin Wealth Management LLC acquired a new position in GE HealthCare Technologies in the 3rd quarter valued at $31,000. Continuum Advisory LLC lifted its position in shares of GE HealthCare Technologies by 101.8% during the 3rd quarter. Continuum Advisory LLC now owns 333 shares of the company’s stock valued at $31,000 after acquiring an additional 168 shares during the period. Finally, Bank of Jackson Hole Trust acquired a new stake in shares of GE HealthCare Technologies during the 4th quarter worth $32,000. Institutional investors own 82.06% of the company’s stock.

GE HealthCare Technologies Trading Up 0.3 %

GEHC opened at $85.59 on Wednesday. The company has a debt-to-equity ratio of 0.88, a current ratio of 1.04 and a quick ratio of 0.83. GE HealthCare Technologies Inc. has a fifty-two week low of $74.51 and a fifty-two week high of $94.80. The company’s 50 day moving average price is $87.06 and its two-hundred day moving average price is $86.17. The firm has a market capitalization of $39.14 billion, a price-to-earnings ratio of 19.77, a PEG ratio of 3.19 and a beta of 1.13.

GE HealthCare Technologies (NASDAQ:GEHC) last posted its quarterly earnings data on Thursday, February 13th. The company reported $1.45 earnings per share for the quarter, beating analysts’ consensus estimates of $1.26 by $0.19. The business had revenue of $5.32 billion during the quarter, compared to the consensus estimate of $5.33 billion. GE HealthCare Technologies had a return on equity of 25.74% and a net margin of 10.13%. As a group, research analysts predict that GE HealthCare Technologies Inc. will post 4.68 earnings per share for the current year.

Analyst Ratings Changes

A number of research analysts recently commented on the company. The Goldman Sachs Group raised GE HealthCare Technologies from a “neutral” rating to a “buy” rating and boosted their price target for the company from $85.00 to $100.00 in a research note on Tuesday. Citigroup boosted their target price on shares of GE HealthCare Technologies from $103.00 to $110.00 and gave the company a “buy” rating in a research report on Thursday, February 13th. Wells Fargo & Company increased their price target on shares of GE HealthCare Technologies from $96.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, February 14th. Finally, Jefferies Financial Group upgraded shares of GE HealthCare Technologies from a “hold” rating to a “buy” rating and boosted their price objective for the company from $95.00 to $103.00 in a research report on Wednesday, January 8th. One research analyst has rated the stock with a sell rating, two have given a hold rating, nine have assigned a buy rating and one has issued a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $98.75.

GE HealthCare Technologies Company Profile

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.